Nav: Home

Heart attack care in Sweden superior to UK

September 02, 2019

People suffering from heart attacks in Sweden were less likely to die from them in the short and long-term than those in England and Wales, according to a new study.

Researchers, led by the University of Leeds, have for the first time compared the care of the entire populations of Sweden, England and Wales, revealing the superior quality of care in the Scandinavian state.

Lead author Dr Oras Alabas, from the University of Leeds' School of Medicine, said: "Whilst Sweden and the UK both have high performing nationwide health systems, these results demonstrate that there are still improvements to be made when caring for heart attack patients.

"Our findings suggest that the increased use of invasive treatments and recommended medications in Sweden could be causing these differences in mortality.

"The NHS generally does a very good job of looking after heart attack patients, but this data suggests we can build on this great care by learning from our European neighbours."

Their study, published in the journal Cardiovascular Research, compared the treatment and outcomes of over 180,000 patients in Sweden to over 660,000 patients in the UK.

They found that patients who experienced the most severe form of heart attack, known as STEMI, had a net probability of death, defined as the probability of dying due to heart attack and not from other causes, of 6.7% in Sweden compared to 8.0% in the UK, in the one-month following their heart attacks. There was no difference in mortality due to their heart attack from one year after the event onwards for STEMI patients in Sweden compared with the UK.

For the less severe form of heart attack, called NSTEMI, they found that in the following one month from the onset of heart attack, patients from Sweden had a net probability of death of 4.9% compared to 6.8% for those from the UK. The net probability of death from one year after the heart attack onwards was 18.3% for patients in Sweden compared with 21.4% for patients in the UK.

The probabilities are not an individual's probability of dying, but the probability that if they die it was because of their heart attack, and not a different cause of death.

These probabilities therefore indicate how likely it is that a particular health problem will be an individual's cause of death, and thus how well patients are being treated for their heart attacks.

Co-author Professor Chris Gale, from the University of Leeds, said: "Population-based international research is a critical next step if we are to improve how we care for patients with cardiovascular disease.

"This study clearly shows that whilst the NHS is delivering very good care for patients with heart attack, improvements can still be made, which will result in a reduction in potentially avoidable deaths."
-end-


University of Leeds

Related Heart Attack Articles:

Heart cells respond to heart attack and increase the chance of survival
The heart of humans and mice does not completely recover after a heart attack.
A simple method to improve heart-attack repair using stem cell-derived heart muscle cells
The heart cannot regenerate muscle after a heart attack, and this can lead to lethal heart failure.
Mount Sinai discovers placental stem cells that can regenerate heart after heart attack
Study identifies new stem cell type that can significantly improve cardiac function.
Fixing a broken heart: Exploring new ways to heal damage after a heart attack
The days immediately following a heart attack are critical for survivors' longevity and long-term healing of tissue.
Heart patch could limit muscle damage in heart attack aftermath
Guided by computer simulations, an international team of researchers has developed an adhesive patch that can provide support for damaged heart tissue, potentially reducing the stretching of heart muscle that's common after a heart attack.
How the heart sends an SOS signal to bone marrow cells after a heart attack
Exosomes are key to the SOS signal that the heart muscle sends out after a heart attack.
Heart attack patients taken directly to heart centers have better long-term survival
Heart attack patients taken directly to heart centers for lifesaving treatment have better long-term survival than those transferred from another hospital, reports a large observational study presented today at Acute Cardiovascular Care 2019, a European Society of Cardiology congress.
Among heart attack survivors, drug reduces chances of second heart attack or stroke
In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.
Oxygen therapy for patients suffering from a heart attack does not prevent heart failure
Oxygen therapy does not prevent the development of heart failure.
I have had a heart attack. Do I need open heart surgery or a stent?
New advice on the choice between open heart surgery and inserting a stent via a catheter after a heart attack is launched today.
More Heart Attack News and Heart Attack Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.